Utah Medical Products, Inc. Announces Executive Changes
April 02, 2018 at 12:14 pm EDT
Share
Utah Medical Products, Inc. announced that on April 2, 2018, Paul O. Richins resigned as principal financial officer of the company due to his retirement. Mr. Richins is continuing as a member of the board of directors, including standing for re-election at the annual meeting of stockholders on May 4, 2018. On April 2, 2018, Brian L. Koopman was appointed principal financial officer of the company. Mr. Koopman has served as the Company's Controller since 2006. There have been no related party transactions.
Utah Medical Products, Inc. is engaged in the business of producing medical services. The Company markets a range of medical devices used in critical care areas, especially the neonatal intensive care unit (NICU), the labor and delivery (L&D) department and the women's health center in hospitals, as well as medical devices sold to outpatient clinics and physician's offices. Its products include BT-CATH, CVX-RIPE, AROM-COT, MUC-X, CORDGUARD, DISPOSA-HOOD, DELTRAN PLUS, GESCO, PICC-NATE, LETZ System, Filshie Clip System, PATHFINDER PLUS, SUPRAPUBIC CATHETERIZATION, LIBERTY System, ENDOCURETTE, LUMIN, and BioPharm HP-PRT, among others. BT-CATH is a uterine balloon tamponade catheter for controlling severe postpartum hemorrhage. MUC-X is an aspiration device used immediately after birth to clear neonatal respiratory passages and reduce exposure to potential infections. AROM-CO is a finger cover with a prong designed to rupture maternal membranes with less patient pain and anxiety.
UTAH MEDICAL PRODUCTS, INC. 